Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review.

Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot L, Sedat J, Fontaine D, Bourg V, Martis N, Lebrun-Frenay C.

Neurol Neuroimmunol Neuroinflamm. 2019 May 7;6(4):e568. doi: 10.1212/NXI.0000000000000568. eCollection 2019 Jul. Review.

2.

Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy.

Jomier F, Bousson V, Viala K, Péréon Y, Magot A, Cauquil C, Bouhour F, Vial C, Bedat-Millet AL, Taithe F, Bresch S, Siri A, Kubis N, Lozeron P.

Eur J Neurol. 2020 Jan;27(1):181-187. doi: 10.1111/ene.14053. Epub 2019 Aug 12.

PMID:
31348848
3.

Impact of executive dysfunction on naming ability in multiple sclerosis.

Joly H, Cohen M, Bresch S, Lebrun-Frenay C.

Rev Neurol (Paris). 2019 Oct;175(9):552-559. doi: 10.1016/j.neurol.2019.02.008. Epub 2019 Jun 17. No abstract available.

PMID:
31221416
4.

Digestive side-effects with teriflunomide: Thoughts on lactose.

Lebrun C, Bertagna M, Bresch S, Cohen M.

Rev Neurol (Paris). 2018 Dec;174(10):722-725. doi: 10.1016/j.neurol.2017.11.010. Epub 2018 Nov 5.

PMID:
30409479
5.

Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders.

Lebrun C, Cohen M, Rosenthal-Allieri MA, Bresch S, Benzaken S, Marignier R, Seitz-Polski B, Ticchioni M.

Neurol Ther. 2018 Dec;7(2):373-383. doi: 10.1007/s40120-018-0101-4. Epub 2018 Jun 7.

6.

Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis.

Lebrun C, Bourg V, Bresch S, Cohen M, Rosenthal-Allieri MA, Desnuelle C, Ticchioni M.

J Neuroimmunol. 2016 Sep 15;298:79-81. doi: 10.1016/j.jneuroim.2016.07.009. Epub 2016 Jul 11.

PMID:
27609279
7.

Hybridization trends for main group elements and expanding the Bent's rule beyond carbon: more than electronegativity.

Alabugin IV, Bresch S, Manoharan M.

J Phys Chem A. 2014 May 22;118(20):3663-77. doi: 10.1021/jp502472u. Epub 2014 May 8.

PMID:
24773162
8.

[Electrodiagnostic criteria for early diagnosis of bulbar-onset ALS: a comparison of El Escorial, revised El Escorial and Awaji algorithm].

Bresch S, Delmont E, Soriani MH, Desnuelle C.

Rev Neurol (Paris). 2014 Feb;170(2):134-9. doi: 10.1016/j.neurol.2013.10.004. Epub 2013 Nov 14. French.

PMID:
24239347
9.

MyD88 is involved in myeloid as well as lymphoid hematopoiesis independent of the presence of a pathogen.

Fiedler K, Kokai E, Bresch S, Brunner C.

Am J Blood Res. 2013 May 5;3(2):124-40. Print 2013.

10.

Brain natriuretic peptide: a relevant marker to rule out delayed atrial fibrillation in stroke patient.

Suissa L, Bresch S, Lachaud S, Mahagne MH.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e103-10. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.010. Epub 2012 Sep 23.

PMID:
23010631
11.

Multi-enzymatic one-pot reduction of dehydrocholic acid to 12-keto-ursodeoxycholic acid with whole-cell biocatalysts.

Sun B, Kantzow C, Bresch S, Castiglione K, Weuster-Botz D.

Biotechnol Bioeng. 2013 Jan;110(1):68-77. doi: 10.1002/bit.24606. Epub 2012 Sep 18.

PMID:
22806613
12.

[Hematological side effects of natalizumab: Correlation with clinical outcome].

Bresch S, Cohen M, Rocher F, Laffon M, Thomas P, Lebrun C.

Rev Neurol (Paris). 2012 Feb;168(2):116-20. doi: 10.1016/j.neurol.2011.07.013. Epub 2011 Nov 17. French.

PMID:
22100322
13.

Complex shapes and dynamics of dissolving drops of dichloromethane.

Pimienta V, Brost M, Kovalchuk N, Bresch S, Steinbock O.

Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10728-31. doi: 10.1002/anie.201104261. Epub 2011 Sep 28. No abstract available.

PMID:
21956951

Supplemental Content

Loading ...
Support Center